Source link : https://www.newshealth.biz/health-news/vibegron-benefit-extends-to-men-on-benign-prostatic-hyperplasia-meds/
Men pharmacologically treated for benign prostatic hyperplasia (BPH) experienced significant improvements in overactive bladder (OAB) symptoms after treatment with vibegron (Gemtesa), according to results from a phase III randomized trial. After 12 weeks of treatment, vibegron recipients experienced significant reductions in average daily micturition episodes (-2.04 with vibegron vs -1.30 with placebo, P
Author : News Health
Publish date : 2024-07-10 17:38:51
Copyright for syndicated content belongs to the linked Source.
Categories